A Long Term Safety Study of BCX7353 in Hereditary Angioedema

NCT03472040 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema
HAE
Prophylaxis

Interventions

DRUG: BCX7353

Sponsor

BioCryst Pharmaceuticals